Results 161 to 170 of about 19,047 (198)

An ounce of prevention is better : Monitoring wildlife health as a tool for pandemic prevention. [PDF]

EMBO Rep
Gogarten JF, Düx A, Gräßle T, Lumbu CP, Markert S, Patrono LV, Pléh KA, Singa FN, Tanga CTF, Tombolomako TB, Couacy-Hymann E, Kouadio L, Ahuka-Mundeke S, Makouloutou-Nzassi P, Calvignac-Spencer S, Leendertz FH.   +15 more
europepmc   +1 more source

Global distribution and genetic diversity of orthoebolaviruses: Mapping and evolutionary analysis. [PDF]

One Health
Cheng N, Ye RZ, Li YY, Kargbo KB, Ren LL, Cao WC.   +5 more
europepmc   +1 more source

Serological Survey in African Nonhuman Primate Species in Cameroon and the Democratic Republic of the Congo Reveals Low Overall Seroprevalence to Mpox Virus. [PDF]

J Infect Dis
Biai N, Ndimbo-Kumugo SP, Loul S, Bass IN, Champagne M, Kingebeni PM, Delaporte E, Muyembe-Tamfum JJ, Kouanfack C, Ayouba A, Ahuka-Mundeke S, Peeters M.   +11 more
europepmc   +1 more source

Identification of potential biomarkers and drug of ischemic stroke in patients with COVID-19 through machine learning. [PDF]

Heliyon
Wang S, Tai Y, Yang X, Li P, Wang H, Tan Y, Gao T, Chu M, Liu M.   +8 more
europepmc   +1 more source

Detection of novel coltivirus-related sequences in Haemaphysalis megaspinosa ticks collected from Kanagawa Prefecture, Japan. [PDF]

J Vet Med Sci
Matsumura R, Kobayashi D, Itoyama K, Isawa H.   +3 more
europepmc   +1 more source

MALAT1 and HIST1H2BC as connecting diagnostic biomarkers in Ebola and its overlapping disease: An integrative approach. [PDF]

Bioinformation
Hayat S, Raza K, Ahmad MM, Ali R, Tamkeen N, Veg A, Khan N, Saleem F, Ishrat R.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Science Translational Medicine
The Janssen Ebola virus (EBOV) vaccine consists of the adenovirus type 26 vector encoding the EBOV glycoprotein (GP) (Ad26.ZEBOV) and the modified vaccinia Ankara (MVA) vector encoding GP from EBOV, Sudan virus, and Marburg virus and nucleoprotein from ...
T. Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, B. Beckman, Yifan Li, Aljawharah Alrubayyi, Daniel J. Curtis, Zhanna Shubin, Michael D Barrera, Jacob Boeckelman, Shayla Duncan, Pallavi Thapa, Dohoon Kim, Margaret C Costanzo, Hongjun Bai, Bethany L. Dearlove, Jay W Hooper, S. Kwilas, Dominic Paquin-Proulx, M. Eller, L. Eller, H. Kibuuka, Betty Mwesigwa, Josphat Kosgei, Fredrick Sawe, Janet Oyieko, N. Ntinginya, Joel Mwakisisile, I. Jani, Edna O Viegas, M. Iroezindu, A. Akintunde, Kristopher Paolino, M. Robb, Lucy Ward, Chelsea McLean, K. Luhn, Cynthia Robinson, J. Ake, M. Rolland   +39 more
semanticscholar   +1 more source

Pre-clinical evaluation of immunogenicity and protective efficacy of a pan-orthoebolavirus virus-like particle (VLP) vaccine 3075

Journal of Immunology
Development of pan-orthoebolavirus vaccines to prevent Ebola disease and to induce durable protective immunity remains an important unmet need. Current Ebola virus (EBOV) vaccines have been reported to protect humans only against EBOV, one of the ...
Karnail Singh, Hung Le, Bishal Marasini, Peng Xiao, François J. Villinger, Kyle L. O’Donnell, Andrea Marzi, Paul W. Spearman   +7 more
semanticscholar   +1 more source

Therapeutics development for Ebola virus disease: A recent scenario.

Current opinion in pharmacology (Print), 2021
C. Chakraborty
semanticscholar   +1 more source